KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 26th Apr 2024 ADXS stock ended at $0.555. This is 0.91% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 0.91% from a day low at $0.550 to a day high of $0.555.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Mar 07, 2016 $139.05 $139.05 $139.05 $139.05 110 327
Mar 04, 2016 $129.60 $129.60 $129.60 $129.60 110 373
Mar 03, 2016 $115.05 $115.05 $115.05 $115.05 126 593
Mar 02, 2016 $112.05 $112.05 $112.05 $112.05 177 840
Mar 01, 2016 $88.50 $88.50 $88.50 $88.50 35 313
Feb 29, 2016 $81.90 $81.90 $81.90 $81.90 37 967
Feb 26, 2016 $87.00 $87.00 $87.00 $87.00 37 840
Feb 25, 2016 $84.15 $84.15 $84.15 $84.15 36 640
Feb 24, 2016 $85.20 $85.20 $85.20 $85.20 44 853
Feb 23, 2016 $86.55 $86.55 $86.55 $86.55 39 333
Feb 22, 2016 $94.20 $94.20 $94.20 $94.20 39 113
Feb 19, 2016 $92.85 $92.85 $92.85 $92.85 37 520
Feb 18, 2016 $88.20 $88.20 $88.20 $88.20 35 773
Feb 17, 2016 $94.50 $94.50 $94.50 $94.50 44 913
Feb 16, 2016 $92.25 $92.25 $92.25 $92.25 40 727
Feb 12, 2016 $88.20 $88.20 $88.20 $88.20 46 767
Feb 11, 2016 $83.25 $83.25 $83.25 $83.25 45 333
Feb 10, 2016 $81.90 $81.90 $81.90 $81.90 49 013
Feb 09, 2016 $83.25 $83.25 $83.25 $83.25 56 180
Feb 08, 2016 $88.65 $88.65 $88.65 $88.65 63 007
Feb 05, 2016 $95.25 $95.25 $95.25 $95.25 48 027
Feb 04, 2016 $102.30 $102.30 $102.30 $102.30 54 227
Feb 03, 2016 $97.65 $97.65 $97.65 $97.65 53 860
Feb 02, 2016 $98.25 $98.25 $98.25 $98.25 46 340
Feb 01, 2016 $105.00 $105.00 $105.00 $105.00 52 980
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT